Literature DB >> 8344571

Crohn's disease: the genetic contribution.

J Sofaer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8344571      PMCID： PMC1374217          DOI： 10.1136/gut.34.7.869

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  51 in total

1.  Evidence that autoimmunity in man is a Mendelian dominant trait.

Authors:  W B Bias; J D Reveille; T H Beaty; D A Meyers; F C Arnett
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

2.  Marital idiopathic inflammatory bowel disease. Crohn's disease in a husband and wife.

Authors:  C J Murray; A B Thomson
Journal:  J Clin Gastroenterol       Date:  1988-02       Impact factor: 3.062

3.  The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives.

Authors:  W Küster; L Pascoe; J Purrmann; S Funk; F Majewski
Journal:  Am J Med Genet       Date:  1989-01

4.  High prevalence of antibodies to intestinal epithelial antigens in patients with inflammatory bowel disease and their relatives.

Authors:  C Fiocchi; J K Roche; W M Michener
Journal:  Ann Intern Med       Date:  1989-05-15       Impact factor: 25.391

5.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking.

Authors:  C Tysk; E Lindberg; G Järnerot; B Flodérus-Myrhed
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

Review 6.  Alterations of the immune system in ulcerative colitis and Crohn's disease.

Authors:  R P MacDermott; W F Stenson
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

7.  Hermansky-Pudlak syndrome: an immunologic assessment of 15 cases.

Authors:  F Shanahan; L Randolph; R King; R Oseas; M Brogan; C Witkop; J Rotter; S Targan
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

8.  Restriction fragment length polymorphism analysis of T-cell receptor genes in inflammatory bowel disease.

Authors:  S Katakura; K Einarsson; L Hammarström; C I Smith
Journal:  Scand J Gastroenterol       Date:  1989-04       Impact factor: 2.423

9.  HLA antigens and clinical manifestations in Crohn's disease.

Authors:  V Modena; A Amoroso; C Frattasio; A Pera; P Costantini; I Maiocco; V Ponti; C C Di Vittorio; G Verme; E S Curtoni
Journal:  Clin Exp Rheumatol       Date:  1988 Jul-Sep       Impact factor: 4.473

10.  Prevalence and incidence of inflammatory bowel disease in family members.

Authors:  B A Lashner; A A Evans; J B Kirsner; S B Hanauer
Journal:  Gastroenterology       Date:  1986-12       Impact factor: 22.682
View more
  5 in total

1.  Evolutionary meta-analysis of association studies reveals ancient constraints affecting disease marker discovery.

Authors:  Joel T Dudley; Rong Chen; Maxwell Sanderford; Atul J Butte; Sudhir Kumar
Journal:  Mol Biol Evol       Date:  2012-03-01       Impact factor: 16.240

2.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

3.  Estimating the total number of susceptibility variants underlying complex diseases from genome-wide association studies.

Authors:  Hon-Cheong So; Benjamin H K Yip; Pak Chung Sham
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

4.  Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution.

Authors:  Natalia Gorlatova; Kinlin Chao; Lipika R Pal; Rawan Hanna Araj; Andrey Galkin; Illarion Turko; John Moult; Osnat Herzberg
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

5.  Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases.

Authors:  Diana Chang; Feng Gao; Andrea Slavney; Li Ma; Yedael Y Waldman; Aaron J Sams; Paul Billing-Ross; Aviv Madar; Richard Spritz; Alon Keinan
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.